Moderna Vaccine Trial: How Upbeat Coronavirus News Fueled a Stock Surge
The desperate hunt for treatments and vaccines has changed how researchers, regulators, drug companies like Moderna, investors and journalists do their jobs. https://nyti.ms/2ZHR359
In a rare in-depth interview, this billionaire man of mystery, the head of Palantir Technologies, talks about war, A.I. and America’s future. https://nyti.ms/3WOsRK7
The digital media company, which will merge with a publicly listed shell company in what is known as a SPAC deal, also lined up about $150 million in debt financing. https://nyti.ms/2SXcq1k
